
The Kyiv regional office of Ukraine’s Antimonopoly Committee of Ukraine (AMCU) has launched a probe into whether prices of polymerase chain reaction (PCR) tests for the coronavirus are competitive.
The probe was initiated by member of Kyiv City Council Oleksandr Brodsky, AMCU chief Oleksiy Khmelnitskyy said on Facebook on August 18. “The information provided in the motion may indicate there are signs of violations of competition laws, namely, anticompetitive concerted actions or abuse of monopoly position in actions of medical laboratories in Kyiv, suppliers and/or manufacturers of PCR tests,” he wrote. According to Khmelnitskyy, the official price of a COVID-19 test is high.
Full Content: UNIAN
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Appeals Court Temporarily Halts Ruling in Consumer Bureau Battle
Apr 3, 2025 by
CPI
Capital One-Discover $35 Billion Merger Moves Forward After DOJ Decision
Apr 3, 2025 by
CPI
RealPage Sues Berkeley Over Ban on Rental Pricing Software
Apr 3, 2025 by
CPI
Olivia Trusty’s FCC Nomination Set for Senate Hearing Next Week
Apr 3, 2025 by
CPI
Amazon Challenges France’s Book Delivery Fee at EU Court
Apr 3, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – China Edition: Year of the Snake
Apr 3, 2025 by
CPI
The Fair Competition Review and the Unified National Market in China
Apr 3, 2025 by
Sen La & Wei Han
Facing the Conundrums: China’s Antitrust Policy Amid Geopolitical Shifts
Apr 3, 2025 by
Da Shi
Concentrations in China in 2023 and 2024
Apr 3, 2025 by
John Yong Ren, Karen Mei & Martha Shu Wen
SAMR’s Evolving Role on the Geopolitical Chessboard
Apr 3, 2025 by
Andrew Foster, Danette Chan & Flora Xiao